TREATMENT FOR RECURRENT GLIOBLASTOMA: ARE THERE SUCCESSES?

The paper analyzes treatments for glioblastoma. The role of resurgery, reradiotherapy, and antitumor drug therapy in the treatment of recurrent glioblastoma has been studied. Multicenter trials of the use of temozolamide and temozolomide in combination with bevacizumab have been reviewed. It has been shown that the use of bevacizumab to treat patients with glioblastoma makes it possible to increase survival and to improve quality of life

POSTTREATMENT NEUROBLASTOMA MATURATION TO GANGLIONIC CELL TUMOR

Tumor cells can differentiate into more mature forms in undifferentiated or poorly differentiated tumors, such as medulloblastomas with increased nodularity, as well as neuroblastomas. The authors describe 2 cases of neuroblastoma maturation into ganglioneuroblastoma 5 months after chemotherapy in a 2-year-old girl and 3 years after radiotherapy in a 16-year-old girl